C3d-defined complement receptor-binding peptide p28 conjugated to circumsporozoite protein provides protection against Plasmodium berghei

被引:24
作者
Bergmann-Leitner, Elke S.
Duncan, Elizabeth H.
Leitner, Wolfgang W.
Neutzner, Albert
Savranskaya, Tatyana
Angov, Evelina
Tsokos, George C.
机构
[1] Walter Reed Army Inst Res, Div Malaria Vaccine Dev, Silver Spring, MD 20910 USA
[2] NIH, Dermatol Branch, Ctr Canc Res, Bethesda, MD 20892 USA
[3] NINDS, Surg Neurol Branch, NIH, Bethesda, MD 20852 USA
[4] Walter Reed Army Inst Res, Div Entomol, Silver Spring, MD 20910 USA
[5] Harvard Univ, Sch Med, Beth Israel Deaconess Med Ctr, Div Rheumatol, Boston, MA 02115 USA
关键词
molecular adjuvant; DNA vaccines; complement C3d;
D O I
10.1016/j.vaccine.2007.08.030
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Immune response against circumsporozoite protein (CSP) of Plasmodium berghei, a major surface protein on the sporozoite, confers protection in various murine malaria models. Engineered DNA vaccine encoding CSP and 3 copies of C3d caused an unexpected loss in protection attributed to the binding of C3d to the C-terminal region of CSP. Because the C3d region known as p28 represents the complement receptor (CR) 2-binding motif, we developed a CSP-3 copies of p28 DNA construct (CSP-3p28). CSP-3p28-immunized mice were better protected against P.berghei sporozoites than CSP-immunized mice 6 weeks after the 2nd boost, produced sufficient IgGl anti-CSP and CSP C-terminus antibody and failed to produce IgG2a. CSP-3C3d-immunized mice were not protected, failed to produce IgG l and produced high amounts of IgG2a. We conclude that use of the CR2-binding motif of C3d as molecular adjuvant to CSP results in anti-malaria protective immune response probably by targeting the chimeric protein to CR2. Published by Elsevier Ltd.
引用
收藏
页码:7732 / 7736
页数:5
相关论文
共 10 条
[1]   Complement 3d: From molecular adjuvant to target of immune escape mechanisms [J].
Bergmann-Leitner, Elke S. ;
Leitner, Wolfgang W. ;
Tsokos, George C. .
CLINICAL IMMUNOLOGY, 2006, 121 (02) :177-185
[2]   C3d binding to the circumsporozoite protein carboxy-terminus deviates immunity against malaria [J].
Bergmann-Leitner, ES ;
Scheiblhofer, S ;
Duncan, EH ;
Leitner, WW ;
Chen, D ;
Angov, E ;
Khan, F ;
Williams, JL ;
Winter, DB ;
Thalhamer, J ;
Lyon, JA ;
Tsokos, GC .
INTERNATIONAL IMMUNOLOGY, 2005, 17 (03) :245-255
[3]   C3d of complement as a molecular adjuvant: Bridging innate and acquired immunity [J].
Dempsey, PW ;
Allison, MED ;
Akkaraju, S ;
Goodnow, CC ;
Fearon, DT .
SCIENCE, 1996, 271 (5247) :348-350
[4]   Cutting edge: C3d functions as a molecular adjuvant in the absence of CD21/35 expression [J].
Haas, KM ;
Toapanta, FR ;
Oliver, JA ;
Poe, JC ;
Weis, JH ;
Karp, DR ;
Bower, JF ;
Ross, TM ;
Tedder, TF .
JOURNAL OF IMMUNOLOGY, 2004, 172 (10) :5833-5837
[5]  
Leitner WW, 1997, J IMMUNOL, V159, P6112
[6]  
Scheiblhofer S, 2001, EUR J IMMUNOL, V31, P692, DOI 10.1002/1521-4141(200103)31:3&lt
[7]  
692::AID-IMMU692&gt
[8]  
3.0.CO
[9]  
2-Y
[10]  
TSOKOS GC, 1990, J IMMUNOL, V144, P1640